ClinConnect ClinConnect Logo
Search / Trial NCT06847685

Mechanisms of Uterine Fluid Absorption During Early Pregnancy ( ELF Study)

Launched by JOHNS HOPKINS UNIVERSITY · Feb 21, 2025

Trial Information

Current as of July 25, 2025

Recruiting

Keywords

Endometriosis Endometrial Biopsy

ClinConnect Summary

The ELF Study is a clinical trial designed to understand how the uterus absorbs fluid during early pregnancy, particularly in women with conditions like endometriosis or endometriomas. Researchers are looking for healthy women between 18 and 45 years old, including those diagnosed with endometriosis or infertility and those without these conditions. To participate, women should have regular menstrual cycles and a body mass index (BMI) between 18 and 40. Importantly, participants must not be pregnant or have certain reproductive health issues.

If you qualify and decide to join the study, you will help researchers learn more about the early stages of pregnancy and how the uterus functions. Your involvement will include providing consent for the study procedures and sharing some health information. This research aims to improve our understanding of uterine health, which could benefit women facing fertility challenges in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Subject must be a healthy woman between the ages of 18 and 45 years.
  • 2. Women with diagnosed endometriosis or infertility (cases).
  • 3. Women without a diagnosis of endometriosis or infertility (controls).
  • 4. Subject must have regular menstrual cycles.
  • 5. Subject must have a body mass index (BMI) between 18 and 40.
  • 6. Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum.
  • 7. Subject must be able to understand and provide consent to procedures and use/disclosure of protected health information.
  • 8. No history of Chlamydia trachomatis, Mycoplasma genitalium, Neisseria gonorrhoeae, hepatitis B, and HIV.
  • 9. For IVF study subjects, a minimum endometrial thickness of 7mm at the time of sample collection.
  • Exclusion Criteria:
  • 1. Pregnant women.
  • 2. Study subjects with endometrial cancer.
  • 3. Study subjects with a history of endometrial ablation.
  • 4. Study subjects with undiagnosed uterine bleeding.
  • 5. Women with reproductive diseases that affect the endometrium (such as fibroids or uterine polyps that distort endometrial cavity).
  • 6. Study subjects with an intrauterine device (IUD).

About Johns Hopkins University

Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.

Locations

Baltimore, Maryland, United States

Athens, Georgia, United States

Piscataway, New Jersey, United States

Patients applied

0 patients applied

Trial Officials

James Segars, MD

Study Chair

Johns Hopkins University

Bhuchitra Singh, MD, MPH, MS, MBA

Study Director

Johns Hopkins University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported